BWS
BSX icon

Broadway Wealth Solutions’s Boston Scientific BSX Stock Holding History

Broadway Wealth Solutions’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
+6,881
New +$374K 0.14% 70

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Broadway Wealth Solutions's BSX Position: Q2 2026 in Review

Broadway Wealth Solutions opened a new position in Boston Scientific (BSX) in Q2 2026: 6,881 shares worth $294K. The stake represents 0.14% of the portfolio and ranks #70 among its holdings.

225 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Broadway Wealth Solutions held 6,881 shares of Boston Scientific worth $294K as of Q2 2026.
  • Boston Scientific was a new Broadway Wealth Solutions position in Q2 2026.
  • Boston Scientific made up 0.14% of Broadway Wealth Solutions's portfolio in Q2 2026, its #70 holding.
  • 225 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Broadway Wealth Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.